Page last updated: 2024-09-03

calpain inhibitor 2 and Inflammation

calpain inhibitor 2 has been researched along with Inflammation in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CH; Huang, L; Hung, HY; Kim, SY; Lee, KH; Qian, K	1
Bertino, P; Hara, JH; Hashimoto, AS; Hoffmann, FW; Hoffmann, PR; Huang, Z; Mafnas, C; Rose, AH	1

Other Studies

2 other study(ies) available for calpain inhibitor 2 and Inflammation

Article	Year
New betulinic acid derivatives as potent proteasome inhibitors. Bioorganic & medicinal chemistry letters, 2011, Oct-01, Volume: 21, Issue:19 Topics: Antineoplastic Agents; Betulinic Acid; Chymotrypsin; Cysteine Proteinase Inhibitors; Drug Design; Inflammation; Molecular Structure; Molecular Targeted Therapy; Neoplasms; Pentacyclic Triterpenes; Proteasome Inhibitors; Signal Transduction; Structure-Activity Relationship; Triterpenes	2011
Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer. Inflammatory bowel diseases, 2015, Volume: 21, Issue:9 Topics: Animals; Azoxymethane; Cell Proliferation; Colitis; Colonic Neoplasms; Cytokines; Dextran Sulfate; Disease Models, Animal; HT29 Cells; Humans; I-kappa B Proteins; Inflammation; Injections, Intraperitoneal; Macrophage Activation; Mice; NF-kappa B; Oligopeptides; Translocation, Genetic	2015

Article

Year

New betulinic acid derivatives as potent proteasome inhibitors.

Bioorganic & medicinal chemistry letters, 2011, Oct-01, Volume: 21, Issue:19

Topics: Antineoplastic Agents; Betulinic Acid; Chymotrypsin; Cysteine Proteinase Inhibitors; Drug Design; Inflammation; Molecular Structure; Molecular Targeted Therapy; Neoplasms; Pentacyclic Triterpenes; Proteasome Inhibitors; Signal Transduction; Structure-Activity Relationship; Triterpenes

2011

Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer.

Inflammatory bowel diseases, 2015, Volume: 21, Issue:9

Topics: Animals; Azoxymethane; Cell Proliferation; Colitis; Colonic Neoplasms; Cytokines; Dextran Sulfate; Disease Models, Animal; HT29 Cells; Humans; I-kappa B Proteins; Inflammation; Injections, Intraperitoneal; Macrophage Activation; Mice; NF-kappa B; Oligopeptides; Translocation, Genetic

2015